Resources

Resources

Webinar

Advances in Patient Data Refinement and Analytics

Join us at our new webinar: Advances in Patient Data Refinement and Analytics. This webinar will be hosted by Sean McCarthy, Segment Leader, Patient Access and Ed Doran, Solutions Manager. In this webinar we will focus on how patient data quality issues remain a...

View Webinar

Webinar

2021 Federal FSS Public Law Pricing Requirements for Manufacturers

Join us at our new webinar: 2021 Federal FSS Public Law Pricing Requirements for Manufacturers. This webinar will be hosted by Annamarie Lee, Director, Advisory Services. This webinar will provide you with a background of what to expect for the upcoming season and walk...

View Webinar

Webinar

Gross-to-Net Launch Readiness for Cell & Gene Therapies

CGT companies seeking to maximize success for newly launched therapies understand that Gross-to-Net (GTN) – when done right – can improve patient access to therapies while driving revenues. This webinar focuses on mission-critical GTN activities for cell and gene therapy companies planning for commercial...

View Webinar

Webinar

CMS Proposed Rule – Exploring the Potential Impact to Manufacturers

Join us at our new webinar: CMS Proposed Rule - Exploring the Potential Impact to Manufacturers. This webinar will be hosted by Rupal Patel, Director, Advisory Services and Carmela Crimeni, Director, Advisory Services. In this webinar, we will attempt to demystify the potential impact...

View Webinar

Article

Strategies for Effective Patient Services Programs

As you well know, patient adherence to therapy continues to be a challenge for manufacturers. New complex patient journeys and multi-channel brand distribution models make it increasingly difficult to address patient barriers to adherence. If you’re like most manufacturers, you’re heavily invested in patient...

Read Article

Blog

Real-Time Data Insights and Actionability All in Single Access-Specific Platform

The latest ICyte Platform Summer Release is all about data actionability. We’ve now made it easier than ever to provide better, deeper visibility into your data within our single access platform so you can proactively simplify your everyday tasks and spend less time dealing...

Read Blog Post

Paper

The Case for a Market Access Platform

Increasingly, pharmaceutical manufacturers are realizing that an effective and efficient market access strategy requires careful and coordination management of contracts, pricing, channel and patient data, patient services and gross-to-net processes. Traditionally, this has been performed by different parts of the organization with limited sharing...

Download Paper

Webinar

Contracting Implications for Cell & Gene Therapies

Cell and Gene Therapy companies have unique pricing and contracting strategies that can impact government program access. Join IntegriChain’s Jeff Baab and as the do a “deep-dive” into contracting strategies and considerations. Topics to be explored include: Key market considerations, such as payer coverage and...

View Webinar

Paper

IntegriChain’s Data Stewardship and Analytics Solutions for Specialty Pharmaceuticals

This paper will focus on IntegriChain's solutions for data stewardship and analytics, with an emphasis on the improved operational benefits pharmaceutical manufacturers can realize in working with their specialty pharmacy partners.

Download Paper

Webinar

Considerations for Operationalizing Claim Level Validation (CLD) in Medicaid Rebate Processes

Join us at our new webinar: Considerations for Operationalizing Claim Level Validation (CLD) in Medicaid Rebate Processes. This webinar will be hosted by Manish Rathod, Segment Lead, Contracts and Pricing, James Perry, Manager, Product Development - Medicaid Rebates and Medicaid CLD, and Chad...

View Webinar

Webinar

Launch Readiness for Cell & Gene Therapies in the Government & Commercial Channels

Readying for the Government and Commercial Channels is an important launch preparedness step for CGT companies. This webinar from IntegriChain expert Jeff Baab will present crucial contracts and pricing timelines and milestones to get contracts in place for Day 1 readiness. Additional topics to...

View Webinar

Case Study

Sharing a Platform Vision for Launch Success

Read how IntegriChain's market access platform and vision was the perfect match for this innovative manufacturer of dermatologic therapies.

Read Case Study

Case Study

Ensuring Day 1 Readiness for Innovative Oncology Therapy

Learn how IntegriChain helped an emerging pharmaceutical manufacturer prepare for Day 1 readiness, even with an imminent launch window.

Read Case Study

eBook

The 5-Step Process for Ensuring Launch Readiness

This eBook highlights a market-tested, 5-step process for ensuring Day 1 readiness for launch. 

Download eBook

Blog

The Four Challenge Cases in Patient Data Mastering

One of the data quality challenges that we’ve been tackling here at IntegriChain is an issue that really seems to be resonating with life sciences access teams lately: data quality concerns around patient identifiers or patient mastering. We have spent a lot of our...

Read Blog Post

Webinar

Impact of COVID-19 on the Pharmaceutical Channel VOL. 3

Join us in our third part of our COVID-19 webinar series. This event will focus on updates plus new investigations in the dynamics of specialty brands from a channel and patient journey perspective. In other words we’ll look into demand and supply trends but...

View Webinar

Webinar

Overcoming the Patient Data Mastering Challenge to Improve Specialty Pharmacy Performance

Join us for this webinar where we will be sharing the challenges with patient mastering and how technological innovations can handle missing data, spelling mistakes and other data errors. Learn how to identify and solve inaccurate patient data!

View Webinar

Case Study

Leveraging an Access Platform to Achieve Commercialization Excellence

This case study shows how an emerging pharmaceutical manufacturer partnered with IntegriChain to ensure Day 1 readiness for their new therapy.

Read Case Study

Paper

Top 10 Gross-to-Net Practices for Launch

This white paper focuses on the Top 10 Gross-to-Net Accounting Practices for Successful Product Launches in the Life Sciences Industry. 

Download Paper

Webinar

Impact of COVID-19 on the Pharmaceutical Channel VOL. 2

Join us in our second part of our COVID-19 webinar series. This event will focus on updates plus new investigations in the dynamics of specialty brands from a channel and patient journey perspective. In other words we’ll look into demand and supply trends but...

View Webinar

Webinar

Impact of COVID-19 on the Pharmaceutical Channel

Join us for this important webinar where we will be discuss and analyze the impact of COVID-19 on distributor inventories, downstream inventories, demand, and supply chain omits. We will also be sharing early results on our recent Channel Data Benchmark and Analysis Study. Be...

View Webinar

Webinar

Using Return & Inventory Analytics to Improve Gross to Net Forecasting

Join us for this webinar where we will be sharing updated pipeline days-on-hand (DOH) benchmarks and a case study highlighting the improvement in accuracy of Gross to Net revenue forecasting when incorporating DOH data and analytics.

View Webinar

Webinar

Best Practices for Tracking and Reporting Potentially Inappropriate Sales of Controlled Substances

Join us for this webinar where we will present the best practices on reaching effective order management to limit a manufacturer’s susceptibility to price speculation and serve as a safeguard against suspicious orders of highly-regulated, controlled drugs.

View Webinar

Webinar

Launch Essentials: Timelines and Best Practices for Setting Up Government Pricing, Rebates, Chargebacks & GTN Processes

Join us for this webinar where we will present the best practices on launch readiness, designing optimal contract strategies, challenging and capturing rebate dollars, validating checks and blind spots in chargebacks, and automation benefits of GTN. 

View Webinar

Webinar

Specialty Pharmacy Data Contracts: 3 Insights You Need to Know Before Renewing

Join us for this webinar where We’ll discuss what defines a “bad contract,” how to identify what you need in your contract and what is typically missing, how to effectively renegotiate data contracts and enforce accountability.

View Webinar

Webinar

Benchmarks and Trends for Controlling Cross-Channel Revenue Leakage

Join us for this webinar when we'll present the latest 340B benchmarks and usage trends in critical therapeutic areas: Oncology, Immunology, and Virology (HCV, HBV and HIV). We also will review the latest best practices to prevent duplicate discounts and other potential program violations.

View Webinar

Webinar

Sales Performance Tracking for Modern Channels

The channels by which patients access therapies continues to evolve and expand. During this webinar, we will walk through case studies on how we have helped manufacturers navigate this challenge and make sure your sales compensation programs are timely and accurate.

View Webinar

Webinar

ICyte Fall Release Preview

Join Melissa O'Neal, Segment Leader, Distribution, and Sunay Shah, VP of Product Management for our webinar introducing the Fall 2019 ICyte Release. Melissa and Sunay will demonstrate key new features and functionality, including: Scheduled Reporting, Spotfire X Upgrade, Distribution Contract Management Reporting, Order Management...

View Webinar

Webinar

GTN Industry Insights

Provided by Jen Sharpe, CBI GTN Summit chairperson powered by Revenue Analytics Collaborative Survey Sponsored by IntegriChain and CBI.

View Webinar

Infographic

Specialty Product Launch: Data and Analytics Strategy Checklist

IntegriChain has helped a number of leading specialty brands across therapeutic areas develop and implement a specialty data & analytics strategy for launch. We've consolidated a list of best practices including SP data contracting, de-identification/tokenization, data quality, data warehouse integration, and patient journey analytics...

View Infographic

Webinar

Pricing Transparency: Building a Compliance Framework

This webinar discusses some of the new pricing laws coming online as well as adjustments to consider in your compliance monitoring framework. Webinar attendees will receive information on key legislative trends, understand implications on pricing and launch programs and review key elements of a...

View Webinar

Blog

5 Steps to a Better Specialty Data Contracting Strategy

An effective specialty data contracting strategy starts at the finish line and works backward. The decisions made in terms of data fields, sub-status granularity, reporting frequency, and contact language, determine the metric outputs that are possible. This post looks at how the right specialty...

Read Blog Post

Blog

Utilizing AI and Machine Learning to Predict Challenging Patient Cases

IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients who are likely to experience roadblocks in their journey -- before the roadblocks occur. Predictive...

Read Blog Post

Article

Using Patient Access Insights to Tailor Delivery of Services

In 2018, the US FDA approved 63 novel drugs and biologics—and a staggering 44 of the approved products are considered specialty. The prevalence of specialty products launching and progressing through the development pipeline is giving rise to a nearly equal number of Patient Support...

Read Article

Blog

Cancellation Reasons Highlight the Opportunity to Proactively Support Stalled Patient Cases

The quality of status and sub-status data reported by SPs is an ongoing challenge that limits the actionability of data specialty brands have contracted to receive. Clearly, poor data quality limits the level of insights that analytics can surface for key stakeholders. Simply cleansing...

Read Blog Post

Webinar

The Opportunity for Data Science to Improve Patient Adherence

This webinar takes a deep dive into analytics that identify highlight (and predict) the drivers of primary and secondary medication non-adherence. We'll explore how diagnostic insights can help your teams identify and act on the patient journey barriers that delay therapy initiation and negatively...

View Webinar

Webinar

Challenges of Integrating Specialty Pharmacy Data, Syndicated Claims and Channel Data

Please join us for this session in our Access Insights webinar series exploring the challenges of calculating total inventory pipeline for specialty products. In this webinar, we will be joined by a few of IntegriChain's top Subject Matter Experts who will discuss their first...

View Webinar

Infographic

Specialty Pharmacy Patient Data Excellence

Poor quality SP data is preventing brands from taking actions that help patients start on therapy faster and stay on therapy longer. What are the steps required to improve data quality and achieve true patient access visibility? Through our work with leading specialty brands...

View Infographic

Webinar

Gross-to-Net Roadmap to Launch

The Roadmap to Launch webinar is a comprehensive countdown of the key gross-to-net (GTN) milestones your team needs to achieve as you prepare for launch. During this webinar we'll share specific insights from companies like yours to highlight different approaches to the most complex...

View Webinar

Webinar

GTN Automation Series: Leveraging Distribution Data for More Powerful Pipeline and Returns Reserves

Please join us for the first session in our webinar series exploring the benefits, trends, and winning strategies for Gross-to-Net Automation. We begin this series by reiterating best practices and exploring modern options for automating and optimizing channel distribution datasets when setting pipeline and...

View Webinar

Webinar

Launch Readiness for Commercial Contracting and Government Programs: Coverage & Policy Trends

Join us for the first in a series of webinars focused on Access Launch Readiness. We’ll start this series with our new daVIZta colleagues for a great entry point for emerging Life Sciences manufacturers who are planning their launch within the next two years....

View Webinar

Webinar

Strategies for Data-Driven Field Reimbursement Teams

Facilitating patient access to prescribed specialty therapeutics continues to be a challenge in a difficult managed care environment. Patients need help navigating obstacles that delay therapy initiation, such as prior authorization and rising out-of-pocket costs, and cause interruptions in treatment. Field Reimbursement (FRM) teams...

View Webinar

Webinar

The Current State of Specialty Patient Status Data and How Specialty Brands Can Improve Data Quality

Missing patient status updates, limited granularity, and inaccurate information all contribute to poor patient journey visibility. A lack of insights into each individual patient journey make it exceedingly difficult to manage a specialty brand. How then, can specialty brands cultivate true patient journey insights...

View Webinar

Webinar

Specialty Pharmacy Data Strategy: Contracting for the Right Data

How will you use analytics to measure commercial success and improve patient experience for your specialty brand? An effective specialty data contracting strategy starts at the finish line and works backward. The decisions you make in terms of data fields, sub-status granularity, reporting frequency,...

View Webinar

Blog

Opioid Crisis Exposes Vulnerabilities in Suspicious Order Monitoring

The American opioid crisis exposed gaps in the reporting systems designed to flag suspicious orders of pharmaceutical products classified as controlled substances. Pharma manufacturers are now facing increased scrutiny and need a new approach to suspicious order monitoring. In this post, IntegriChain Solutions Principal...

Read Blog Post

Webinar

10 Fascinating Insights from Pharmacy Channel Data

Join us for this webinar where we will be sharing results from our recent Channel Data Benchmark and Analysis Study. We're sure you'll be amazed at how much additional insight you can get from your data!

View Webinar

Webinar

How to Self Police Revenue Leakage Due to 340B Program Non-Compliance

There is broad agreement across the pharmaceutical industry and Congress that that 340B program needs more oversight and statutory change. But with so much congressional paralysis and midterm elections on the horizon, it’s highly unlikely that changes will occur anytime soon. The status quo...

View Webinar

Blog

3 Key Opportunities to Improve Specialty Patient Initiation

Prior Authorization (PA) is required for nearly all specialty products and is largely responsible for delayed patient initiation. Lengthy PA delays can ultimately result in cancellations for new patient referrals, adherence/persistence problems, and lower patient satisfaction. There are several ways specialty brands can improve...

Read Blog Post

Blog

The Economics of Rare Disease and Implications for Payer Contract Strategy

Rare diseases affect 30 million people in the United States, which roughly equates to 10% of the population. In 2017, 40% of the novel drugs approved by the FDA were designated to treat a rare disease. As approvals for rare disease treatments increase, these...

Read Blog Post

Infographic

Commercial Readiness Timeline

Based on our experience as the access operations team and data platform for more than 100 pharma companies that are launching novel drugs in the US, we've developed a Commercial Readiness Timeline guide--taking you from 12-months pre-launch for readiness to 12-months post-launch for commercialization--that...

View Infographic

Paper

Using Market Analogs for FP&A During Product Launch

Estimating the value of net sales adjustments from a Finance perspective can be very difficult due to a lack of available data and market information. The problem is especially acute before launch and in the first few quarters the product is on the market....

Download Paper

Webinar

Formulary and Contract Compliance – Uncover Rebate Savings and Reduce Financial Risk

IntegriChain Market Access has been able to leverage subject matter expertise, tools, and techniques to identify between 1.25% and 2.5% of a payers' total rebate spend as non-compliant. In this webinar, our in-house experts John Still and Tina Cullen highlight how two critical compliance...

View Webinar

Webinar

Best Practices in Specialty Data Services Contracts

The expansion of specialty networks to include more pharmacies, and the growing complexity within these networks, is forcing manufacturers to make trade offs as they contract for data critical to understanding and impacting the patient journey. In this webinar, we look at how the...

View Webinar

Webinar

Contracting & Pricing Product Launch Strategies for Small- and Mid-Sized Pharma

The list of challenges associated with commercializing a product is long and diverse. Every decision seems to affect patient access to your product and has long-term implications on growth and profitability. Too often manufacturers make commercialization decisions, negotiate agreements, and set prices that aren't...

View Webinar

Webinar

Controlling Risks through Order Management: Addressing Price Transparency Laws and the Opioid Crisis

The need for the type of accountability provided by order management technology has never been greater. Price Transparency legislation passed in a handful of states in 2017, including California. Additional states are working on their own bills. These laws have the potential to encourage...

View Webinar

Webinar

Using Analytics to Identify High Value, Under Indexed Retail Pharmacies

Multiple factors are challenging patients as they seek access to innovative brands at the retail pharmacy. Complicated payer/plan policy restrictions, including prior authorizations, often delay initiation of therapy. Escalating out-of-pocket costs are another obstacle patients must navigate. This webinar highlights how IntegriChain Retail Analytics...

View Webinar

Case Study

Optimize Rebate Investments with PBMs & HMOs

A manufacturer had historically based Managed Care pricing decisions on highly subjective information and emotion rather than historical data on customer and contract performance. Limited and inaccurate data led to impromptu “how are we doing?” check-in calls. As a result, members of the Pricing...

Read Case Study

Case Study

Improving Managed Care ROI

A disconnect existed between the contract negotiation business function and the contract analyst business function. The belief was that contract performance was not meeting expectations set at the outset of the agreement. We applied a Rational Pricing methodology to help the manufacturer determine if...

Read Case Study

Article

Use Data Analytics to Monitor 340B Discount Drug Pricing

As the industry refocuses on more innovative, expensive specialty drugs and channel designs shift, however, manufacturers are growing increasingly concerned with the 340B Drug Discount Program. Analytics will help manufacturers in their quest to discern how and where products are discounted.

Read Article

Paper

The Value of the 1%

Manufacturers know that ensuring product availability is very difficult, especially when product distribution is so expensive. Further complicating matters, sales do not equal demand, leading to a real commerce optimization problem within the demand network.

Download Paper

eBook

Leaving the Legacy

Pharmaceutical manufacturers continue to struggle with ensuring product availability, controlling distribution cost, and increasing forecast accuracy. This is often because they are using outdated or constrained legacy platforms. In this ebook, learn how three of our customers moved away from disparate systems to IntegriChain’s...

Download eBook

eBook

Mobile-Optimized Channel Management and Demand Sensing Analytics

The latest release of the IntegriChain channel management cloud offers mobile user access and near real-time demand sensing to maximize the accessibility and value of channel data through the life sciences supplier enterprise.

Download eBook

Webinar

Using Channel Data Analytics for 340B Monitoring and Audit Support

IntegriChain Director of Solution Engineering Dave Weiss and guest speaker Michael Townsend, IDC Health Insights Research Manager, Life Sciences Business Systems Strategies explore the changing breadth of the 340B Discount Drug Program and the insights offered in the Health Resources and Services Administration’s (HRSA’s) recently released mega-guidance, including results...

View Webinar

Webinar

Outside-In Order Management

IntegriChain and Lora Cecere, Founder & CEO of Supply Chain Insights, take a deep dive into the new “outside-in” methodology of using actual channel data to make informed order decisions. Lora focuses on how suppliers can use advanced analytics to sense order flows and...

View Webinar

eBook

The Impact of Downstream Inventory on Gross-to-Net Accounting

In this webinar, we explore best practices for estimating inventory when calculating gross-to-net to eliminate gross overstatements or understatements of pipeline liabilities that do not triangulate well with other commercial commerce datasets. Attendees will learn about best practices for using auditor-approved downstream inventory data...

Download eBook

Webinar

IntegriChain Builder Intelligence Tool

Builder radically improves the actionability of channel analytics, driving down the cost of total ownership of wholesaler and specialty data sources while maximizing the value of manufacturer investments in data agreements. This webinar covers merging disparate data sources into one report or visualization, manipulating...

View Webinar

Article

Finding the Value in Outsourced Contract Administration

The growing complexity of managed markets contract support makes outsourcing a near-necessity for emerging pharmaceutical companies, and a better option for big pharma.

Read Article

eBook

The Value of 1%

Manufacturers know that ensuring product availability is very difficult, especially when product distribution is so expensive. Further complicating matters, sales do not equal demand, leading to a real commerce optimization problem within the demand network. Download The Value of 1% White Paper to explore...

Download eBook

eBook

Daily Business Management Trade & Channel

In today’s era of Pay-for-Performance agreements and lean channel inventory, pharmaceutical manufacturers want to know how to better align product availability with the overall cost of distribution. The answer can be found in a new approach to trade data utilization called Daily Business Management....

Download eBook

Blog

Leveraging Distributor Contract Management to Optimize Evolving DSAs

As distribution service agreements evolve over time, manufacturers must have the ability to run what-if analyses on actual scorecard data to analyze the overall effect various changes under consideration would have on trade partner payments. In this post, we look at how Distributor Contract...

Read Blog Post

Blog

Specialty Pharmacy Status/Sub-Status Analysis Highlights Inconsistencies in Data Quality

IntegriChain examined the quality and granularity of status/sub-status data across 40 specialty pharmacies representing different classes of trade (small independent, mid-sized payer, large PBM, etc.). The records we combed through included 15 specialty brands in five therapeutic categories: Immunology, Hematology, Virology, Oncology, and Pulmonary/Respiratory....

Read Blog Post

Webinar

Unlock the Power of Scorecard Analytics to Maximize Pay-for-Performance

This webinar covers major enhancements to trade partner scorecard functionality found within IntegriChain Distribution Analytics. These enhancements allow Scorecard users to utilize robust trade partner agreement data to further maximize pay-for-performance by analyzing channel investment against performance through IntegriChain's powerful Data on Demand and...

View Webinar

Article

How Not to Handle Rebates

As financial pressures increase, pharmaceutical companies are paying greater attention to cutting costs and increasing efficiency. However, rebate expenditures continue to expand.

Read Article

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand